Literature DB >> 21329644

Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.

R Pebody1, P Hardelid, Dm Fleming, J McMenamin, N Andrews, C Robertson, Dr Thomas, P Sebastianpillai, J Ellis, W Carman, T Wreghitt, M Zambon, Jm Watson.   

Abstract

This study provides mid-season estimates of the effectiveness of 2010/11 trivalent influenza vaccine and previous vaccination with monovalent influenza A(H1N1)2009 vaccine in preventing confirmed influenza A(H1N1)2009 infection in the United Kingdom in the 2010/11 season. The adjusted vaccine effectiveness was 34% (95% CI: -10 - 60%) if vaccinated only with monovalent vaccine in the 2009/10 season; 46% (95% CI: 7 - 69%) if vaccinated only with trivalent influenza vaccine in the 2010/11 season and 63% (95% CI: 37 - 78%) if vaccinated in both seasons.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21329644

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  23 in total

1.  Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.

Authors:  Peng Yang; Li Zhang; Weixian Shi; Guilan Lu; Shujuan Cui; Xiaomin Peng; Daitao Zhang; Yimeng Liu; Huijie Liang; Xinghuo Pang; Quanyi Wang
Journal:  Influenza Other Respir Viruses       Date:  2011-12-30       Impact factor: 4.380

Review 2.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

3.  Influenza vaccines differentially regulate the interferon response in human dendritic cell subsets.

Authors:  Shruti Athale; Romain Banchereau; LuAnn Thompson-Snipes; Yuanyuan Wang; Karolina Palucka; Virginia Pascual; Jacques Banchereau
Journal:  Sci Transl Med       Date:  2017-03-22       Impact factor: 17.956

Review 4.  Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.

Authors:  Andrew J Broadbent; Kanta Subbarao
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

5.  Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study.

Authors:  Christof David Vinnemeier; Johanna Fischer-Herr; Seetha Meyer; Katja Liebig; Wiebke Theeß; Gerd-Dieter Burchard; Jakob P Cramer
Journal:  Hum Vaccin Immunother       Date:  2013-11-15       Impact factor: 3.452

6.  Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.

Authors:  James E Fielding; Kristina A Grant; Katherine Garcia; Heath A Kelly
Journal:  Emerg Infect Dis       Date:  2011-07       Impact factor: 6.883

7.  Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus.

Authors:  S Kurečić Filipović; I Gjenero-Margan; E Kissling; B Kaić; A Cvitković
Journal:  Epidemiol Infect       Date:  2015-01-08       Impact factor: 4.434

8.  Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.

Authors:  R G Pebody; N Andrews; D M Fleming; J McMenamin; S Cottrell; B Smyth; H Durnall; C Robertson; W Carman; J Ellis; P Sebastian-Pillai; M Zambon; C Kearns; C Moore; D Rh Thomas; J M Watson
Journal:  Epidemiol Infect       Date:  2012-06-13       Impact factor: 4.434

9.  Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study.

Authors:  Iván Martínez-Baz; Víctor Martínez-Artola; Gabriel Reina; Marcela Guevara; Manuel García Cenoz; Julio Morán; Fátima Irisarri; Maite Arriazu; Esther Albeniz; Jesús Castilla
Journal:  BMC Public Health       Date:  2013-03-06       Impact factor: 3.295

10.  Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach.

Authors:  Angelia A Eick-Cost; Katie J Tastad; Alicia C Guerrero; Matthew C Johns; Seung-Eun Lee; Victor H Macintosh; Ronald L Burke; David L Blazes; Kevin L Russell; Jose L Sanchez
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.